The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. TPR, VRT, CLS and COR are some such stocks.

Cencora Launches Next-Generation Nucleus® Solution with Multi-Site Pilot Across Specialty Physician Practices

08:00am, Wednesday, 17'th Jun 2026

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global pharmaceutical solutions company, today announced a multi-site pilot of its enhanced Nucleus® inventory management solution, designed to help spe

Cencora Announces Samantha Hammock as Chief Human Resources Officer

04:15pm, Monday, 15'th Jun 2026

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that Silvana Battaglia, Executive Vice President and Chief Human Resources Officer (CHRO), has announced she will retire f

2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now

10:45am, Tuesday, 09'th Jun 2026

The shares of both stocks are down so far this year. Stevanato is benefiting from the need for GLP-1 injectables.

Cencora's Specialty Supply Chain: Where COR's Growth Is Headed

03:16pm, Friday, 05'th Jun 2026

COR bets on MSOs, specialty logistics and AI tools to deepen ties beyond distribution???even as GLP-1 mix and pricing swings cloud results.

Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue?

12:36pm, Friday, 05'th Jun 2026

Cencora (COR) reported earnings 30 days ago. What's next for the stock?

Wall Street Analysts Predict a 33.55% Upside in Cencora (COR): Here's What You Should Know

10:57am, Friday, 05'th Jun 2026

The mean of analysts' price targets for Cencora (COR) points to a 33.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR

10:00am, Thursday, 04'th Jun 2026

NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cencora, Inc. ("Cencora" or the "Company") (NYSE: COR). Such investors are advised to contact Dan

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR

04:57pm, Tuesday, 02'nd Jun 2026

NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cencora, Inc. (“Cencora” or the “Company”) (NYSE: COR). Such investors are advised

Cencora to Support U.S. Distribution of Kite's CAR T-Cell Therapies

08:00am, Tuesday, 02'nd Jun 2026

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora today announced an agreement with Kite, a Gilead Company, to support the distribution of Kite's U.S. Food and Drug Administration (FDA)-approved CAR T-cell

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR

10:21am, Thursday, 28'th May 2026

NEW YORK, May 28, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cencora, Inc. ("Cencora" or the "Company") (NYSE: COR). Such investors are advised to contact Dan

CAH vs. COR: Which Healthcare Distributor Stock Is the Better Buy?

12:11pm, Wednesday, 27'th May 2026

CAH and COR are betting big on specialty pharma, but Cardinal Health???s stronger growth, raised outlook, and broader expansion may set it apart.

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by